for the Period Ended 30 April 2024
Balance sheet | |
Notes |
As at
Notes |
2024 |
2023 |
|
---|---|---|---|
|
£ |
£ |
|
Fixed assets | |||
Tangible assets: | 3 |
|
|
Investments: | 4 |
|
|
Total fixed assets: |
|
|
|
Current assets | |||
Cash at bank and in hand: |
|
|
|
Total current assets: |
|
|
|
Creditors: amounts falling due within one year: |
( |
( |
|
Net current assets (liabilities): |
( |
( |
|
Total assets less current liabilities: |
|
|
|
Provision for liabilities: |
( |
( |
|
Total net assets (liabilities): |
|
|
|
Capital and reserves | |||
Called up share capital: |
|
|
|
Revaluation reserve: | 5 | ||
Profit and loss account: |
|
( |
|
Shareholders funds: |
|
|
The notes form part of these financial statements
The directors have chosen to not file a copy of the company’s profit & loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 April 2024
for the Period Ended 30 April 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 30 April 2024
Total | |
---|---|
Cost | £ |
At 01 May 2023 |
|
At 30 April 2024 |
|
Depreciation | |
At 01 May 2023 |
|
At 30 April 2024 |
|
Net book value | |
At 30 April 2024 |
|
At 30 April 2023 |
|
for the Period Ended 30 April 2024
Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each reporting date. Gains and losses on remeasurement are Recognised in profit or loss for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.
for the Period Ended 30 April 2024
2024 | |
---|---|
£ | |
Balance at 01 May 2023 | |
Surplus or deficit after revaluation | |
Balance at 30 April 2024 |